TRAW

0.175023.91%
CP

Charles Parker

Chief Financial Officer

Mr. Charles Parker is Chief Financial Officer of Traws Pharma, Inc. from October 1, 2025 and was Interim Chief Financial Officer from July 03, 2025 to September 30, 2025. In May 2025, Mr. Parker began serving as a Director at Stout, a global advisory firm specializing in corporate finance and accounting services, which has provided supporting finance and accounting related services to Company since 2024. Prior to joining Stout, from November 2021 to May 2025, Mr. Parker worked as a consultant for LS Associates, where he provided consulting Chief Financial Officer and other finance and accounting related services to various companies on an interim basis, including without limitation, to Pristine Surgical, LLC, ROM Technologies, Inc., Cantana Bio and Zogenix, Inc. (Nasdaq:ZGNX). From January 2021 to November 2021, he served as Controller of Dascena, Inc. Mr. Parker has significant experience in public accounting, having worked at BDO USA, LLP for five years and at Parker, Parker and Associates, PLC for five and a half years. Over the course of his career, he has worked with domestic and international small and mid-cap public and private organizations on numerous IPOs, mergers and acquisitions and financings. Mr. Parker holds a B.S. in Accounting from the Lipscomb University.

Positions